AI-generated summary
The authors reviewed 27 studies of visible LED light therapy for dermatological conditions and compared the doses reported, expressed as equivalent solar exposure time. They report that fluences and wavelengths differed widely across studies, that no study validated its dose, and that only about one third included both a control group and blinded outcome assessment.
- Studies included
- 27
- Who or what was studied
- Studies of visible LED light photobiomodulation for dermatological conditions, including acne vulgaris, wrinkle reduction, wound healing, psoriasis and erythemal index; total patients per study ranged from 14 to 105.
- Wavelengths
- 405, 660 nm
- Limits stated in the abstract
- The abstract describes methodological heterogeneity, lack of dose validation, sponsorship by device manufacturers, and frequent absence of blinding and control groups in the included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The advent of mass-market Light Emitting Diodes (LEDs) has seen considerable interest in potential dermatological applications of LED light photobiomodulation (PBM) for a range of conditions, with a thriving market for direct-to-consumer LED treatments, including red light, blue light, and yellow light wavelengths. Evidence of efficacy is however mixed, and studies report a wide range of irradiances and wavelengths as well as outcome measures, rendering interpretation, comparison, and even efficacy evaluation prohibitive and impeding evidence synthesis.
Methods
This work establishes a model for comparing patient received doses, applying this to existent studies to ascertain potential inhomogeneity in reported doses and wavelengths employed. Patient doses were contrasted to equivalent solar exposure time needed to achieve fluences reported at specified wavelengths in the red light (RL), blue light (BL), and yellow light (YL) portion of the spectrum, yielding a comparison of reported doses to typical solar irradiance at the Earth's surface. Methodological aspects including dose validation, blinding, and bias were also analysed.
Results
27 relevant studies for dermatological conditions including acne vulgaris ([Formula: see text], 33.3%), wrinkle-reduction ([Formula: see text]18.5%), wound-healing ([Formula: see text], 11.1%), psoriasis severity ([Formula: see text], 11.1%), and erythemal index ([Formula: see text], 25.9%) were assessed. Outcome measures were highly heterogeneous between studies, with total patients ranging from 14 - 105 (median: 26). Fluences and wavelengths used in treatment differed over three orders of magnitude across studies even for the same conditions ([Formula: see text], median: [Formula: see text]. Derived equivalent solar time ranged from 0.01-19.35 hours (median: 3.3 hours), with central wavelengths between 405nm (BL) - 660nm (RL). No studies reported any dose validation, 10 (37.0%) were sponsored by the device manufacturer with a further 3 (11.1%) conducted by commercial dermatology practices offering the therapy under investigation. Assessors were unblinded to the treatment/ control groups in 33.3% ([Formula: see text]), while a further 9 (33.3%) did not have any non-light control group, leaving only 33.3% ([Formula: see text] with both control group and blinded outcome assessment.
Conclusions
Results of this analysis suggest that fluences, wavelengths, and effective dose vary inconsistently between studies with often scant biological justification. This analysis suggests that better dose quantification and understanding of the underlying biophysics as well as plausible biological justifications for various wavelengths and fluences are imperative if LED therapy studies for dermatology are to be informative and research replicability improved.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 405nm, 660nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Dose, Photobiomodulation, Control group, Irradiance, Blinding. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.